📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD). (2023)

First Author: Dyson A

Attributed to: Homeostatic control of neuron excitability funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1523/eneuro.0461-22.2023

PubMed Identifier: 37185294

Publication URI: http://europepmc.org/abstract/MED/37185294

Type: Journal Article/Review

Volume: 10

Parent Publication: eNeuro

Issue: 5

ISSN: 2373-2822